CERSI Excipients
  • Home
  • Molecular
  • Oral
  • Unresolved
  • Rarely Used
  • Products
  • APIs

Active Ingredients

  • «
  • 1
  • 2
  • …
  • 7
  • 8 current
  • 9
  • …
  • 56
  • 57
  • »
  • 2021 Total
  • Download
# API Name Structure ZINC IDs
253 BRIVARACETAM BRIVARACETAM ZINC3979899
254 BRODALUMAB
255 BROLUCIZUMAB
256 BROMFENAC SODIUM BROMFENAC SODIUM ZINC2570817
257 BROMOCRIPTINE MESYLATE BROMOCRIPTINE MESYLATE ZINC53683151
258 BROMPHENIRAMINE MALEATE BROMPHENIRAMINE MALEATE ZINC12358683
259 BUDESONIDE BUDESONIDE ZINC3938751
260 BUMETANIDE BUMETANIDE ZINC3813061
261 BUPIVACAINE BUPIVACAINE ZINC1530812
262 BUPIVACAINE HCI
263 BUPIVACAINE HCL
264 BUPIVACAINE HYDROCHLORIDE BUPIVACAINE HYDROCHLORIDE ZINC1530812
265 BUPIVACAINE HYDROCHLORIDE ANHYDROUS
266 BUPIVAINE HCI
267 BUPRENORPHINE BUPRENORPHINE ZINC100373348
268 BUPRENORPHINE HYDROCHLORIDE BUPRENORPHINE HYDROCHLORIDE ZINC100373348
269 BUPROPION HYDROBROMIDE BUPROPION HYDROBROMIDE ZINC20228
270 BUPROPION HYDROCHLORIDE BUPROPION HYDROCHLORIDE ZINC20228
271 BUROSUMAB
272 BUSPIRONE HYDROCHLORIDE BUSPIRONE HYDROCHLORIDE ZINC1530571
273 BUSULFAN BUSULFAN ZINC1530572
274 BUTALBITAL BUTALBITAL ZINC3830347
275 BUTENAFINE HYDROCHLORIDE BUTENAFINE HYDROCHLORIDE ZINC1530975
276 BUTOCONAZOLE NITRATE BUTOCONAZOLE NITRATE ZINC1530973
277 BUTORPHANOL TARTRATE BUTORPHANOL TARTRATE ZINC895301
278 CABAZITAXEL CABAZITAXEL ZINC85536932
279 CABERGOLINE CABERGOLINE ZINC3800008
280 CABOZANTINIB CABOZANTINIB ZINC70466416
281 CABOZANTINIB S-MALATE CABOZANTINIB S-MALATE ZINC70466416
282 CAFFEINE CAFFEINE ZINC1084
283 CAFFEINE CITRATE CAFFEINE CITRATE ZINC895081
284 CALASPARGASE PEGOL
285 CALCIFEDIOL CALCIFEDIOL ZINC12484926
286 CALCIPOTRIENE CALCIPOTRIENE ZINC3921872
287 CALCIPOTRIENE HYDRATE
288 CALCITONIN SALMON

  • «
  • 1
  • 2
  • …
  • 7
  • 8 current
  • 9
  • …
  • 56
  • 57
  • »
  • 2021 Total
  • Download
  • CERSI Center of Excellence in Regulatory Science and Innovation
  • ©2016-2017 CERSI, Teague Sterling, Enkhjargal Algaa and the UC Regents
  • CERSI
  • Home
  • Contact
  • Statistics